David A. Fiellin, MD

Professor of Medicine (General Medicine), in the Institute for Social and Policy Studies and of Public Health (Health Policy); Professor, Investigative Medicine; Director, Community Research and Implementation Core, Center for Interdisciplinary Research on AIDS (CIRA)

Research Interests

Acquired Immunodeficiency Syndrome; Alcoholism; Buprenorphine; Health Policy; HIV; Internal Medicine; Substance Abuse Detection; Substance Abuse Treatment Centers

Public Health Interests

Alcoholism/Alcohol; Substance abuse

Research Organizations

Internal Medicine: General Internal Medicine | play2PREVENT

School of Public Health: Center for Interdisciplinary Research on AIDS

DAHRS

Faculty Research

Psychotherapy Development Center

SBIRT Training in Yale Residency Programs

Substance Abuse Research

Office of Cooperative Research

Research Summary

Dr. Fiellin has focused his scholarly work on the interface between primary care and substance abuse. He conducts research on the transfer of treatment strategies, including opioid agonist treatment with buprenorphine and alcohol pharmacotherapies, from specialized settings to office-based, primary care, emergency department and HIV specialty settings.

Specialized Terms: Substance abuse treatment in primary care; Emergency department and HIV specialty settings opioid agonist treatment with buprenorphine; Pharmacologic treatment of alcohol

Selected Publications

Edit this profile

Contact Info

David A. Fiellin, MD
Patient Care Location
Primary Care Center, Yale-New Haven Hospital
789 Howard Avenue

New Haven, CT 06519
View on map...
Office Location
E.S. Harkness Memorial Hall, Building A
367 Cedar Street, Ste Suite 406A

New Haven, CT 06510
View on map...
Mailing Address
Internal MedicinePO Box 208056
333 Cedar Street

New Haven, CT 06520-8056